Reticulocyte count is the most important predictor of acute cerebral ischemia and high-risk transcranial Doppler in a newborn cohort of 395 children with sickle cell anemia
The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
Abstract
Stroke is a severe clinical manifestation of sickle cell anemia (SCA). Despite the prognostic relevance of transcranial Doppler (TCD), more accurate tools to assess stroke risk in children with SCA are required. Here, we describe the effect of clinical, laboratory, and molecular features on the risk of stroke and high-risk TCD in children from the newborn cohort of Minas Gerais, Brazil. Outcomes studied were acute cerebral ischemia and high-risk TCD. Clinical and hematological data were retrieved from children's records. Genetic markers, which were known for their association with stroke risk, were genotyped by polymerase chain reaction/restriction fragment length polymorphism and sequencing. The cumulative incidence of acute cerebral ischemia by the age of 8 years was 7.4 % and that of high-risk TCD by the age of 11.5 years was 14.2 %. The final multivariate model for acute cerebral ischemia risk included high white blood cell count and reticulocyte count, acute chest syndrome rate, and the single nucleotide polymorphisms (SNPs) TEK rs489347 and TNF-α rs1800629. The model for high-risk TCD included high reticulocyte count and the SNPs TEK rs489347 and TGFBR3 rs284875. Children with risk factors should be considered for intensive risk monitoring and for intervention therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Observational studies have shown that reticulocytosis (149), low HbF levels, leukocytosis (150, 151), and complications such as ACS (81) are associated with an increased risk of stroke.”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [151]
Citations
Cites
Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
Kanda, Y. (2013) · Bone Marrow Transplantation · doi:10.1038/bmt.2012.244 · Cited by 18,767
Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504
The Risk of Transfusion-Transmitted Viral Infections
Schreiber, G. B., Busch, M. P., Kleinman, S. H., & Korelitz, J. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342601 · Cited by 1,867
Adams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390102 · Cited by 1,866
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
Dams, R. O. J. A., Ie, V. I. C. M. C. K., Su, L. E. H., Iles, B. E. F., Ichinsky, E. L. V., Egelow, C. H. P., Bboud, M. I. A., Allagher, D. I. G., Utlar, K., Ichols, F. E. T. N., et al. (2015) · Cited by 1,338
Fiedler, U., Reiss, Y., Scharpfenecker, M., Grunow, V., Koidl, S., Thurston, G., Gale, N. W., Witzenrath, M., Rosseau, S., Suttorp, N., et al. (2006) · Nature Medicine · doi:10.1038/nm1351 · Cited by 933
Kato, G. J., Gladwin, M. T., & Steinberg, M. H. (2007) · Blood Reviews · doi:10.1016/j.blre.2006.07.001 · Cited by 876
Stuart, M. J., & Nagel, R. L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17192-4 · Cited by 819
Discontinuing Prophylactic Transfusions Used to Prevent Stroke in Sickle Cell Disease
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa050460 · Cited by 635
Ware, R. E., Davis, B. R., Schultz, W. H., Brown, R. C., Aygun, B., Sarnaik, S., Odame, I., Fuh, B., George, A., Owen, W., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01041-7 · Cited by 515
Chou, S. T., Jackson, T., Vege, S., Smith-Whitley, K., Friedman, D. F., & Westhoff, C. M. (2013) · Blood · doi:10.1182/blood-2013-03-490623 · Cited by 490
Primary role for adherent leukocytes in sickle cell vascular occlusion: A new paradigm
Turhan, A., Weiss, L. A., Mohandas, N., Coller, B. S., & Frenette, P. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052522799 · Cited by 489
Long‐term stroke risk in children with sickle cell disease screened with transcranial doppler
Adams, R. J., McKie, V. C., Carl, E. M., Nichols, F. T., Perry, R., Brock, K., McKie, K., Figueroa, R., Litaker, M., Weiner, S., et al. (1997) · Annals of Neurology · doi:10.1002/ana.410420505 · Cited by 398
A rapid and reliable 7-deletion multiplex polymerase chain reaction assay for α-thalassemia
Tan, A. S.-C., Quah, T. C., Low, P. S., & Chong, S. S. (2001) · Blood · doi:10.1182/blood.v98.1.250 · Cited by 345
Bernaudin, F., Verlhac, S., Arnaud, C., Kamdem, A., Chevret, S., Hau, I., Coïc, L., Leveillé, E., Lemarchand, E., Lesprit, E., et al. (2011) · Blood · doi:10.1182/blood-2010-06-293514 · Cited by 336
Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia
Sebastiani, P., Ramoni, M. F., Nolan, V., Baldwin, C. T., & Steinberg, M. H. (2005) · Nature Genetics · doi:10.1038/ng1533 · Cited by 334
Pathophysiology and treatment of stroke in sickle-cell disease: present and future
Switzer, J. A., Hess, D. C., Nichols, F. T., & Adams, R. J. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70469-0 · Cited by 309
Miller, S. T., Macklin, E. A., Pegelow, C. H., Kinney, T. R., Sleeper, L. A., Bello, J. A., DeWitt, L. D., Gallagher, D. M., Guarini, L., Moser, F. G., et al. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.117580 · Cited by 287
Stroke Prevention Trial in Sickle Cell Anemia
Adams, R. J., McKie, V. C., Brambilla, D., Carl, E., Gallagher, D., Nichols, F. T., Roach, S., Abboud, M., Berman, B., Driscoll, C., et al. (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00099-8 · Cited by 278
Pegelow, M., Colangelo, M., Steinberg, M., Wright, P., Smith, M., Phillips, M., & Vichinsky, M. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00407-x · Cited by 274
Nocturnal hypoxaemia and central-nervous-system events in sickle-cell disease
Kirkham, F., Hewes, D., Prengler, M., Wade, A., Lane, R., & Evans, J. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04821-2 · Cited by 260
Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia
Zimmerman, S. A., Schultz, W. H., Burgett, S., Mortier, N. A., & Ware, R. E. (2007) · Blood · doi:10.1182/blood-2006-11-057893 · Cited by 217
Declining stroke rates in Californian children with sickle cell disease
Fullerton, H. J., Adams, R. J., Zhao, S., & Johnston, S. C. (2004) · Blood · doi:10.1182/blood-2004-02-0636 · Cited by 187
Gene interactions and stroke risk in children with sickle cell anemia
Hoppe, C., Klitz, W., Cheng, S., Apple, R., Steiner, L., Robles, L., Girard, T., Vichinsky, E., Styles, L., & the CSSCD Investigators (2004) · Blood · doi:10.1182/blood-2003-09-3015 · Cited by 175
Bernaudin, F., Verlhac, S., Chevret, S., Torres, M., Coic, L., Arnaud, C., Kamdem, A., Hau, I., Grazia Neonato, M., & Delacourt, C. (2008) · Blood · doi:10.1182/blood-2008-03-143891 · Cited by 162
Genetic predictors for stroke in children with sickle cell anemia
Flanagan, J. M., Frohlich, D. M., Howard, T. A., Schultz, W. H., Driscoll, C., Nagasubramanian, R., Mortier, N. A., Kimble, A. C., Aygun, B., Adams, R. J., et al. (2011) · Blood · doi:10.1182/blood-2011-01-332205 · Cited by 149
Nébor, D., Bowers, A. S., Hardy‐Dessources, M., Knight‐Madden, J., Romana, M., Reid, H. L., Barthélemy, J., Cumming, V., Hüe, O., Élion, J., et al. (2011) · Haematologica · doi:10.3324/haematol.2011.047365 · Cited by 132
Enninful‐Eghan, H., Moore, R. H., Ichord, R., Smith‐Whitley, K., & Kwiatkowski, J. L. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.03.007 · Cited by 131
Advances in understanding the pathogenesis of cerebrovascular vasculopathy in sickle cell anaemia
Connes, P., Verlhac, S., & Bernaudin, F. (2013) · British Journal of Haematology · doi:10.1111/bjh.12300 · Cited by 111
Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease
VI, J. G. T., Tang, D. C., Savage, S. A., Leitman, S. F., Heller, S. I., Serjeant, G. R., Rodgers, G. P., & Chanock, S. J. (2002) · Blood · doi:10.1182/blood-2001-12-0306 · Cited by 109
Stroke risk in siblings with sickle cell anemia
Driscoll, M. C. (2003) · Blood · doi:10.1182/blood.v101.6.2401 · Cited by 109
Bernaudin, F., Verlhac, S., Arnaud, C., Kamdem, A., Hau, I., Leveillé, E., Vasile, M., Kasbi, F., Madhi, F., Fourmaux, C., et al. (2016) · Blood · doi:10.1182/blood-2015-10-675231 · Cited by 101
Cerebrovascular complications and parvovirus infection in homozygous sickle cell disease
Wierenga, K. J., Serjeant, B. E., & Serjeant, G. R. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.117070 · Cited by 99
How I treat acute chest syndrome in children with sickle cell disease
Miller, S. T. (2011) · Blood · doi:10.1182/blood-2010-11-261834 · Cited by 95
Mortality of children with sickle cell disease: a population study
Fernandes, A. P. P. C., Januário, J. N., Cangussu, C. B., de Macedo, D. L., & Viana, M. B. (2010) · Jornal de Pediatria · doi:10.2223/jped.2005 · Cited by 93
Self-citationMcCarville, M. B., Goodin, G. S., Fortner, G., Li, C., Smeltzer, M. P., Adams, R., & Wang, W. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21430 · Cited by 91
Genetic association studies in β-hemoglobinopathies
Thein, S. L. (2013) · Hematology · doi:10.1182/asheducation-2013.1.354 · Cited by 79
Thangarajh, M., Yang, G., Fuchs, D., Ponisio, M. R., McKinstry, R. C., Jaju, A., Noetzel, M. J., Casella, J. F., Barron‐Casella, E., Hooper, W. C., et al. (2012) · British Journal of Haematology · doi:10.1111/bjh.12034 · Cited by 77
Flanagan, J. M., Sheehan, V., Linder, H., Howard, T. A., Wang, Y., Hoppe, C. C., Aygün, B., Adams, R. J., Neale, G. A. M., & Ware, R. E. (2013) · Blood · doi:10.1182/blood-2012-10-464156 · Cited by 77
Zimmerman, S. A., & Ware, R. E. (1998) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(199812)59:4<267::aid-ajh1>3.0.co;2-w · Cited by 75
Financial analysis of chronic transfusion for stroke prevention in sickle cell disease
Wayne, A. S., Schoenike, S. E., & Pegelow, C. H. (2000) · Blood · doi:10.1182/blood.v96.7.2369 · Cited by 71
Is “Relative” Hypertension a Risk Factor for Vaso-occlusive Complications in Sickle Cell Disease?
Rodgers, G. P., Walker, E. C., & Podgor, M. J. (1993) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199303000-00004 · Cited by 67
Preventing Stroke in Sickle Cell Anemia
Platt, O. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmp058274 · Cited by 60
Meier, E. R., Wright, E. C., & Miller, J. L. (2014) · American Journal of Hematology · doi:10.1002/ajh.23777 · Cited by 59
Utilization of TCD screening for primary stroke prevention in children with sickle cell disease
Armstrong, J., Grimes, B. A., Sidney, S., Kronish, D., SHIBOSKI, S. C., Adams, R. J., & Fullerton, H. J. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a110da · Cited by 59
Prospects for primary stroke prevention in children with sickle cell anaemia
Jordan, L. C., Casella, J. F., & DeBaun, M. R. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.09005.x · Cited by 55
Chaar, V., Laurance, S., Lapouméroulie, C., Cochet, S., Grandis, M. D., Colin, Y., Élion, J., Kim, C. L. V., & Nemer, W. E. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.506121 · Cited by 55
Quinn, C. T., Variste, J., & Dowling, M. M. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07652.x · Cited by 54
Ali, S. B., MooSang, M., King, L., Knight‐Madden, J., & Reid, M. (2011) · American Journal of Hematology · doi:10.1002/ajh.22142 · Cited by 50
Mortalidade de crianças com doença falciforme: um estudo de base populacional
Fernandes, A. P. P. C., Januário, J. N., Cangussu, C. B., de Macedo, D. L., & Viana, M. B. (2010) · Jornal de Pediatria · doi:10.1590/s0021-75572010000400006 · Cited by 48
Self-citationLagunju, I. A., Brown, B. J., & Sodeinde, O. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24698 · Cited by 46
Silva, C. M., Giovani, P., & Viana, M. B. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.22680 · Cited by 43
Self-citationTranscranial Doppler ultrasonography in siblings with sickle cell disease
Kwiatkowski, J. L., Hunter, J. V., Smith‐Whitley, K., Katz, M. L., Justine Shults, A., & Ohene‐Frempong, K. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04276.x · Cited by 40
Hyacinth, H. I., Gee, B. E., Adamkiewicz, T. V., Adams, R. J., Kutlar, A., Stiles, J. K., & Hibbert, J. M. (2012) · Cytokine · doi:10.1016/j.cyto.2012.05.017 · Cited by 39
Sommet, J., Alberti, C., Couque, N., Verlhac, S., Haouari, Z., Mohamed, D., François, M., Missud, F., Holvoet, L., Elmaleh, M., et al. (2016) · British Journal of Haematology · doi:10.1111/bjh.13916 · Cited by 38
Lagunju, I. A., Sodeinde, O., Brown, B. J., Akinbami, F. O., & Adedokun, B. (2013) · Journal of Clinical Ultrasound · doi:10.1002/jcu.22099 · Cited by 37
Belisário, A. R., Martins, M. L., Brito, A. M. S., Velloso‐Rodrigues, C., Silva, C. M., & Viana, M. B. (2010) · Acta Haematologica · doi:10.1159/000320271 · Cited by 37
Self-citationCerebrovascular accidents in sickle cell disease. Risk factors and blood transfusion influence
an behalf of French Study Group on Sickle Cell Disease, de Montalembert, M., Beauvais, P., Bachir, D., Galactéros, F., & Girot, R. (1993) · European Journal of Pediatrics · doi:10.1007/bf01956144 · Cited by 34
Belisário, A. R., Nogueira, F. L., Rodrigues, R. S., de Toledo, N. E., Cattabriga, A. L. M., Velloso‐Rodrigues, C., Duarte, F. O. C., Silva, C. M., & Viana, M. B. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2014.08.001 · Cited by 29
Self-citationBelisário, A. R., Sales, R. R., de Toledo, N. E., Velloso‐Rodrigues, C., Silva, C. M., & Viana, M. B. (2015) · Blood · doi:10.1182/blood-2015-05-645176 · Cited by 24
Self-citationMeier, E. R., Fasano, R. M., Estrada, M., He, J., Luban, N. L. C., & McCarter, R. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.10.031 · Cited by 24
Research works printed but not linked: 1
- Jesus JA, Araujo PIC (2012) Sickle cell disease: basic management for treatment. vol first edition. Ministry of Health, Brasília
Cited by
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Determinants of severity in sickle cell disease
Rees, D. C., Brousse, V. A. M., & Brewin, J. N. (2022) · Blood Reviews · doi:10.1016/j.blre.2022.100983 · Cited by 108
Ataga, K. I., Gordeuk, V. R., Agodoa, I., Colby, J. A., Gittings, K., & Allen, I. E. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229959 · Cited by 58
“3 Risk of PHT Bakanay, 2005 [28] Retrospective US 226 16–68 Mortality Belisario, 2016 [29] Prospective cohort (2 cohorts) Brazil 395 At time of stroke or end of f/u: 4.”
BackgroundGenetic Variation and Sickle Cell Disease Severity: A Systematic Review and Meta-Analysis
Kirkham, J. K., Estepp, J. H., Weiss, M. J., & Rashkin, S. R. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.37484 · Cited by 54
Measuring success: utility of biomarkers in sickle cell disease clinical trials and care
Kalpatthi, R. V., & Novelli, E. M. (2018) · Hematology · doi:10.1182/asheducation-2018.1.482 · Cited by 51
Metadata
- Authors
- Belisário, A. R., Sales, R. R., Toledo, N. E., Muniz, M. B. D. S. R., Velloso-Rodrigues, C., Silva, C. M., & Viana, M. B.
- Affiliations
- Universidade Federal de Minas Gerais (BR)
- Fundação Centro de Hematologia e Hemoterapia de Minas Gerais (BR)
- Corresponding author
- Belisário, André Rolim
- ORCID
- Venue
- Annals of Hematology
- Published
- 2016-08-13
- Volume
- 95
- Issue
- 11
- Pages
- 1869-1880
- ISSN
- 0939-5555 (ISSN-L)
- 1432-0584
- OpenAlex
- W2512353492
- Cited by
- 29
- References
- 63
- Citations by year
- 2026: 2 · 2024: 3 · 2023: 7 · 2022: 5 · 2021: 3 · 2020: 2 · 2019: 1 · 2018: 4 · 2017: 2
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Hematology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais (BR) (PPM-00266-13)
- Conselho Nacional de Desenvolvimento CientÃfico e Tecnológico (304530/2011-5)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal Health and Biochemistry
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Keywords
- sickle cell disease, reticulocyte count, acute cerebral ischemia, stroke risk, children, single nucleotide polymorphisms, acute chest syndrome, white blood cell count, risk prediction
- MeSH terms
- Acute Disease, Anemia, Sickle Cell, Brain Ischemia, Child, Female, Follow-Up Studies, Haplotypes, Humans, Infant, Newborn, Leukocyte Count, Male, Proteoglycans, Risk, Risk Factors, Tumor Necrosis Factor-alpha, Incidence, Ultrasonography, Doppler, Transcranial, Reticulocyte Count, Receptors, Transforming Growth Factor beta, Polymorphism, Single Nucleotide, Receptor, TIE-2, beta-Globins, Acute Chest Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.